We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

By LabMedica International staff writers
Posted on 01 Jun 2023

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. More...

TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through tiny respiratory droplets when a TB-infected individual coughs, sneezes, or talks. Given its high contagion rate, one of the key strategies to curb TB is the early identification of infected patients, thus preventing further spread. Existing TB testing methods, while beneficial, present several drawbacks such as low sensitivity, prolonged wait times for results, and the necessity for specialized lab personnel. To combat these challenges, a research team has created a highly sensitive strip test that can detect TB within two hours.

The MTB Strip TB Test Kit developed by researchers at Chulalongkorn University (Bangkok, Thailand) leverages the technique of genetic material amplification at a constant temperature, alongside a heat box, a common piece of equipment in most labs. This approach is even accessible to small-scale hospitals. To use the MTB Strip TB Test Kit, the patient's sputum is first collected, from which DNA is extracted for use as a template. A specially-crafted primer is used to amplify the genetic material in the pathogen's DNA present in the patient's sputum, a process facilitated by a recombinase polymerase amplification technique that takes merely 20-40 minutes at 37 degrees Celsius. The resulting amplified genetic material is then introduced to the test strip, which displays positive or negative results.

The MTB Strip delivers results with an accuracy rate of up to 96% compared to Realtime PCR and other commonly used acid-resistant dye methods. Moreover, the kit proves more cost-effective than molecular biology tests as it doesn't require specific tools such as a thermocycler. Notably, the MTB Strip demonstrates high sensitivity to TB, capable of detecting even minimal amounts of TB present in sputum. Furthermore, the test is user-friendly, delivers quick and precise results within an hour that can be easily read with the naked eye, and requires no specialized equipment. Despite the satisfactory performance of the MTB Strip kit, the researchers aim to enhance its sensitivity by simplifying the DNA extraction process for use as the kit primer. Currently, they are working on expanding TB and related disease testing by creating an easier-to-use DNA extraction kit and a TB test kit capable of identifying drug-resistant TB strains from the outset, thus allowing for more specific treatment plans.

“We are currently conducting in-depth research on the genetic modification of tuberculosis using a novel technique of genetic modification for a living organism called CRISPR Cas-9 Interference to modify certain TB genes, making the infection less aggressive and more responsive to antituberculosis drugs. CRISPR Cas-9 Interference can be used in conjunction with current antituberculosis drugs,” said Dr. Panan Ratthawongjirakul, Associate Professor at Chulalongkorn University.

Related Links:
Chulalongkorn University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.